The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose
T Tamatsukuri, M Ohbayashi, N Kohyama… - Journal of Infection and …, 2018 - Elsevier
In recent years, augmented renal clearance (ARC), in which renal function is excessively
enhanced, has been reported, and its influence on β-lactam antibiotics has been …
enhanced, has been reported, and its influence on β-lactam antibiotics has been …
Population pharmacokinetic model and dosing simulation of meropenem using measured creatinine clearance for patients with sepsis
S Fukumoto, M Ohbayashi, A Okada… - Therapeutic Drug …, 2023 - journals.lww.com
Purpose: Creatinine clearance (CCr) and pharmacokinetic parameters are markedly
affected by pathophysiological changes in patients with sepsis. However, only a few reports …
affected by pathophysiological changes in patients with sepsis. However, only a few reports …
Population pharmacokinetic analysis of meropenem after intravenous infusion in Korean patients with acute infections
YK Kim, DH Lee, J Jeon, HJ Jang, HK Kim, K Jin… - Clinical …, 2018 - Elsevier
Purpose The aim of this study was to investigate the population pharmacokinetic (PK) profile
of meropenem in Korean patients with acute infections. Methods The study included 37 …
of meropenem in Korean patients with acute infections. Methods The study included 37 …
Does prolonged infusion time really improve the efficacy of meropenem therapy? A prospective study in critically ill patients
YC Zhao, Y Zou, YW Xiao, F Wang, BK Zhang… - Infectious Diseases and …, 2022 - Springer
Introduction Meropenem is a carbapenem antibiotic, which has demonstrated excellent
antimicrobial activity against gram-negative clinical isolates. It is also commonly used in …
antimicrobial activity against gram-negative clinical isolates. It is also commonly used in …
Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis
L Ehmann, M Zoller, IK Minichmayr, C Scharf… - International journal of …, 2019 - Elsevier
Effective antibiotic dosing is vital for therapeutic success in critically ill patients. This work
aimed to develop an algorithm to identify appropriate meropenem dosing in critically ill …
aimed to develop an algorithm to identify appropriate meropenem dosing in critically ill …
Population pharmacokinetics/pharmacodynamics and clinical outcomes of meropenem in critically ill patients
A Boonpeng, S Jaruratanasirikul… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Several pathophysiological changes can alter meropenem pharmacokinetics in critically ill
patients, thereby increasing the risk of subtherapeutic concentrations and affecting …
patients, thereby increasing the risk of subtherapeutic concentrations and affecting …
Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy
A Isla, A Rodríguez-Gascón, IF Trocóniz… - Clinical …, 2008 - Springer
Background and objective: Meropenem is a carbapenem antibacterial frequently prescribed
for the treatment of severe infections in critically ill patients, including those receiving …
for the treatment of severe infections in critically ill patients, including those receiving …
[HTML][HTML] Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent …
S Tournayre, O Mathieu, M Villiet, N Besnard… - International Journal of …, 2023 - Elsevier
Objectives The use of extended intermittent infusion (EII) or continuous infusion (CI) of
meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
meropenem is recommended in intensive care unit (ICU) patients, but few data comparing …
Population pharmacokinetic analysis of meropenem in Japanese adult patients
T Muro, T Sasaki, N Hosaka, Y Umeda… - Journal of clinical …, 2011 - Wiley Online Library
What is known and Objective: Meropenem is frequently employed as an empirical treatment
for serious infections, but there has been no report on its population pharmacokinetic …
for serious infections, but there has been no report on its population pharmacokinetic …
Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in …
S Jaruratanasirikul, S Thengyai… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Pathophysiological changes during the early phase of severe sepsis and septic shock in
critically ill patients, resulting in altered pharmacokinetic (PK) patterns for antibiotics, are …
critically ill patients, resulting in altered pharmacokinetic (PK) patterns for antibiotics, are …